Serine/threonine kinase

25 Items

per page
Set Descending Direction
Catalog No.
Product Name
Product Information
Product Citation
  1. WNK inhibitor

    WNK-IN-11 is an allosteric With-No-Lysine (WNK) kinase inhibitor, with an IC50 of 4 nM for WNK1.
  2. SRPK inhibitor

    SRPIN340 is a cell-permeable isonicotinamide that acts as an ATP-competitive SRPK1-selective inhibitor (IC50 = 0.14 and 1.8 μM, respectively, against mSRPK1 and mSRPK2) with much reduced activity against 143 other kinases.
  3. Megakaryocytes/platelets inducing agent is an inducing agent for megakaryocytes and/or platelets from pluripotent stem cells, the inducing agent being useful in treating diseases involving thrombopenia.
  4. STK33 inhibitor

    ML-281 is a potent ans selective STK33 inhibitor with IC50 value of 14 nM.
  5. pan-WNK-kinase inhibitor

    WNK463 is an orally bioavailable pan-WNK-kinase inhibitor.
  6. GAK inhibitor

    SGC GAK 1 is a high affinity cyclin G associated kinase (GAK) inhibitor.
  7. ATP-competitive STK19 inhibitor

    ZT-12-037-01 is a potent, selective, ATP-competitive STK19 inhibitor. ZT-12-037-01 effectively blocks oncogenic NRAS-driven melanocyte malignant transformation and melanoma growth in vitro and in vivo.
  8. Serine/arginin kinase 1 inhibitor

    SPHINX31 is a potent inhibitor of serine/arginine-rich protein kinase 1 (SRPK1; IC50 = 5.9 nM).
  9. AAK1 inhibitor

    LP-935509 is a potent inhibitor of the Adapter protein-2 Associated Kinase 1 (AAK1).
  10. SRPK1/2 inhibitor

    SRPKIN-1 is a covalent and irreversible SRPK1/2 inhibitor with IC50s of 35.6 and 98 nM, respectively. Anti-angiogenesis effect.
  11. Bub1 inhibitor

    BAY-524 is a Bub1 inhibitor, with an IC50 of 450 nM for human Bub1 in the presence of 2 mM ATP.
  12. Bub1 inhibitor

    BAY-320 is a Bub1 inhibitor, with an IC50 of 680 nM for human Bub1 in the presence of 2 mM ATP.
  13. GCN2 inhibitor

    GCN2iB is an ATP-competitive inhibitor of a serine/threonine-protein kinase general control nonderepressible 2 (GCN2), with an IC50 of 2.4 nM.
  14. BUB1 kinase inhibitor

    BAY-1816032 is a potent and oral available BUB1 (budding uninhibited by benzimidazoles 1) kinase inhibitor with an IC50 of 7 nM.
  15. BUB1 kinase inhibitor

    2OH-BNPP1 is an inhibitor of BUB1 kinase, a Ser/Thr kinase, used for the treatment of cancer.
  16. GCN2 inhibitor

    GCN2-IN-1 (A-92) is a potent general control nonderepressible 2 kinase (GCN2) inhibitor with an IC50 of <0.3 μM in the enzyme assay and an IC50 of 0.3-3 μM in the cell assay.
  17. STK16 kinase inhibitor

    STK16-IN-1 is a STK16 kinase inhibitor with an IC50 of 295 nM.
  18. GSK4027 Negative Control

    GSK4028 is the enantiomeric negative control of GSK4027, which is a PCAF/GCN5 bromodomain chemical probe, the pIC50 of GSK4028 is 4.9 in a time-resolved fluorescence resonance energy transfer (TR-FRET) assay.
  19. PASK inhibitor

    BioE-1115 is a highly selective and potent PAS kinase (PASK) inhibitor with an IC50 of ~4 nM. BioE-1115 is also a potent casein kinase 2α inhibitor with an IC50 of ~10 μM.
  20. DCLK1 domain probe

    DCLK1-IN-1 is a selective, oral bioavailability in vivo-compatible chemical probe of the doublecortin like kinase 1 (DCLK1 kinase) domain.
  21. Serine/Threonine Kinase 16, Mouse Anti Human
  22. Serine/Threonine Kinase 16 Human Recombinant
  23. Serine/Threonine Kinase 17B Human Recombinant
  24. Serine/Threonine Kinase 3 Human Recombinant
  25. Serine/Threonine Kinase 17A Human Recombinant

25 Items

per page
Set Descending Direction